PAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary

Sandusky, OH -- February 3, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced the company anticipates reporting an estimated $50,000 in revenue for Q4 2020.

The revenue is anticipated from a $300,000 sales agreement executed by PAOG’s cannabis cultivation subsidiary.

Last summer, PAOG acquired a cannabis cultivation business from Puration, Inc. (USOTC: PURA).  The acquisition was made in conjunction with PAOG’s overall strategy to refresh and renew its overall cannabis healthcare industry strategy.

Last year, also in conjunction PAOG’s plan to refresh and renew its overall cannabis healthcare industry strategy, the company with PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."

As part of the transaction with PURA, PAOG plans to issue a dividend of one share to PURA shareholders for every one share held of PURA stock.  PAOG and PURA anticipate announcing dividend details soon pending the completion of necessary approvals now underway.

PAOG anticipates approximately $50,000 in revenue per quarter for the next six quarters from the aforementioned $300,000 sales agreement.

Learn more about PAOG at www.paogroupinc.com.
 
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
[e-mail]